Patents by Inventor Manish Chawla

Manish Chawla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXTENDED RELEASE OSMOTIC DOSAGE FORM COMPRISING HIGH METHYLPHENIDATE HYDROCHLORIDE LOAD
    Publication number: 20180360817
    Abstract: The present invention provides an extended release osmotic tablet dosage form comprising methylphenidate hydrochloride (MPH). The dosage form comprises a core tablet comprising methylphenidate hydrochloride in an amount of more than 8% by weight of the core tablet; a semi-permeable membrane surrounding the core tablet, and an immediate release drug coat comprising methylphenidate hydrochloride surrounding the semipermeable membrane.
    Type: Application
    Filed: December 30, 2016
    Publication date: December 20, 2018
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Manish CHAWLA, Shailesh Vishwanath BIRADAR, Mayur LOYA, Jayendrakumar Dasharathlal PATEL, Akshay Virendra AGARWAL
  • Stable orally disintegrating tablets of hyoscyamine
    Patent number: 9456981
    Abstract: The present invention relates to stable orally disintegrating tablets of hyoscyamine or pharmaceutically acceptable salts thereof. The invention also relates to processes for the preparation of such tablets and use thereof.
    Type: Grant
    Filed: February 13, 2015
    Date of Patent: October 4, 2016
    Assignee: Cadila Healthcare Limited
    Inventors: Manish Chawla, Shailesh Biradar, Ajay Kumar Sharma
  • STABLE FORMULATION OF AZACITIDINE OR SALTS THEREOF AND THEIR PROCESS FOR PREPARATION
    Publication number: 20160095925
    Abstract: The present invention relates to a stable pharmaceutical composition comprising azacitidine or its pharmaceutically acceptable salts, one or more sugar alcohols and one or more pharmaceutically acceptable excipients, wherein said composition is suitable for parenteral administration. The invention also relates to processes for preparing the preparation of such reconstitutable formulations. The invention also relates to therapeutic methods of use of such formulations and to use of such formulations in the manufacture of medicaments.
    Type: Application
    Filed: October 1, 2015
    Publication date: April 7, 2016
    Inventors: Manish Chawla, Narendra Soni, Kashyap Nagariya, Sanjay Ghanshyambhai Patel
  • METHOD FOR DETERMINING FORMULATION ORIENTATION OF ASYMMETRIC MULTI-LAYERED OSMOTIC TABLETS
    Publication number: 20160000654
    Abstract: The present invention relates to a method for preparing asymmetric multi-layered osmotic tablets using rapid and accurate determination of the orientation of tablets with respect to different internal formulation layers proximate to the opposite curved surfaces. In particular, the invention relates to detect degree of curvature using an image recognition system and drill the desired surface using a laser beam.
    Type: Application
    Filed: July 6, 2015
    Publication date: January 7, 2016
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Manish CHAWLA, Shailesh Vishwanath BIRADAR, Mahendra PATEL
  • STABLE ORALLY DISINTEGRATING TABLETS OF HYOSCYAMINE
    Publication number: 20150283068
    Abstract: The present invention relates to stable orally disintegrating tablets of hyoscyamine or pharmaceutically acceptable salts thereof. The invention also relates to processes for the preparation of such tablets and use thereof.
    Type: Application
    Filed: February 13, 2015
    Publication date: October 8, 2015
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Manish CHAWLA, Shailesh BIRADAR, Ajay Kumar SHARMA
  • MULTIPLE UNIT MODIFIED RELEASE COMPOSITIONS OF CARBAMAZEPINE AND PROCESS FOR THEIR PREPARATION
    Publication number: 20070071819
    Abstract: The present invention relates to multiple-unit modified release carbamazepine compositions for oral administration which include: (i) at least one extended release unit, and (ii) at least one enteric release unit. Also provided are processes for the preparation of multiple-unit modified release compositions of carbamazepine.
    Type: Application
    Filed: May 30, 2006
    Publication date: March 29, 2007
    Inventors: Amit Kesarwani, Manish Chawla, Rajeev Raghuvanshi, Ashok Rampal
  • Novel method stabilizing bupropion hydrochloride tablets
    Publication number: 20060165779
    Abstract: The present invention relates to a stable bupropion hydrochloride tablet and a method of stabilizing bupropion hydrochloride tablets, which also serves as an improved tabletting process for the preparation of sustained release bupropion hydrochloride tablets.
    Type: Application
    Filed: April 15, 2003
    Publication date: July 27, 2006
    Inventors: Manish Chawla, Rajeev Raghuvanshi, Ashok Rampal
  • Bupropion hydrochloride solid dosage forms
    Publication number: 20060020040
    Abstract: The present invention relates to solid dosage forms that contain bupropion hydrochloride and glucono delta lactone or its corresponding open chain hydroxy acid derivative. The bupropion hydrochloride retains at least 80% of the bupropion hydrochloride potency after storage for three months at 40° C. and 75% relative humidity. The solid dosage form may be in the form of a tablet, a capsule, or a granulate with or without an immediate release profile, a modified release profile, or an extended release profile.
    Type: Application
    Filed: November 17, 2003
    Publication date: January 26, 2006
    Inventors: Manish Chawla, Rajeev Raghuvanshi, Ashok Rampal
  • Sustained release oral dosage forms of gabapentin
    Publication number: 20050158380
    Abstract: The present invention relates to sustained release oral dosage forms of gabapentin and at least one rate controlling polymer, and a process for the preparation of the sustained release oral dosage forms, and a process for the preparation thereof. The sustained release tablet includes gabapentin or a pharmaceutically acceptable salt or hydrates thereof and at least one rate-controlling polymer such that the tablet provides therapeutically effective plasma levels of gabapentin for a period of up to about 12 hours.
    Type: Application
    Filed: June 6, 2003
    Publication date: July 21, 2005
    Inventors: Manish Chawla, Rajeev Raghuvanshi, Ashok Rampal
  • Controlled release tablets of metformin
    Publication number: 20030104059
    Abstract: Controlled-release metformin and processes for their preparation, using a combination of non-ionic and anionic hydrophilic polymers, wherein the total hydrophilic polymer concentration is at least about 16% by weight of the composition.
    Type: Application
    Filed: November 6, 2002
    Publication date: June 5, 2003
    Inventors: Manish Chawla, Rajeev S. Raghuvanshi, Ashok Rampal